Transcarent acquires Accolade for $621M in cash deal led by CEO Glen Tullman, combining health navigation platforms.
Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback